Frovatriptan versus almotriptan for acute treatment of menstrual migraine: Analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study

Journal of Headache and Pain

Volumn 13, Issue 5, 2012, Pages 401-406

  Bartolini, Marco ^a   Giamberardino, Maria Adelaide ^b   Lisotto, Carlo ^c   Martelletti, Paolo ^d   Moscato, Davide ^e   Panascia, Biagio ^f   Savi, Lidia ^g   Pini, Luigi Alberto ^h   Sances, Grazia ⁱ   Santoro, Patrizia ^j   Zanchin, Giorgio ^k   Omboni, Stefano ^l   Ferrari, Michel D ^m   Fierro, Brigida ⁿ   Brighina, Filippo ⁿ  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c Ospedale Civile San Vito al Tagliamento   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^f AO Universitaria Vittorio Emanuele   (Italy)

^g UNIVERSITY OF TURIN   (Italy)

^h UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

ⁱ C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^j SAN GERARDO HOSPITAL   (Italy)

^k UNIVERSITY OF PADOVA   (Italy)

^l ITALIAN INSTITUTE OF TELEMEDICINE   (Italy)

^m LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁿ UNIVERSITY OF PALERMO   (Italy)

more..

Author keywords

Almotriptan; Frovatriptan; Menstrually related migraine; Migraine

Indexed keywords

ALMOTRIPTAN; FROVATRIPTAN;

ADULT; ANALGESIA; ARTICLE; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUAL MIGRAINE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZATION; RECURRENT DISEASE; TREATMENT DURATION;

ADULT; CARBAZOLES; CROSS-OVER STUDIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ITALY; MENSTRUATION DISTURBANCES; MIDDLE AGED; MIGRAINE DISORDERS; PROPORTIONAL HAZARDS MODELS; SEROTONIN RECEPTOR AGONISTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TRYPTAMINES;

EID: 84865205953     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-012-0455-4     Document Type: Article

References (42)

1. Martin VT, Lipton RB (2008) Epidemiology and biology of menstrual migraine. Headache 48(Suppl 3):S124-S130
2. Taylor FR (2009) Clinical aspects of perimenstrual headaches. Curr Pain Headache Rep 13:75-81
3. Allais G, Castagnoli Gabellari I, De Lorenzo C, Mana O, Benedetto C (2007) Menstrual migraine: clinical and therapeutical aspects. Expert Rev Neurother 7:1105-1120 (Pubitemid 47451018)
4. Mannix LK, Files JA (2005) The use of triptans in the management of menstrual migraine. CNS Drugs 19:951-972 (Pubitemid 41573611)
5. Facchinetti F, Allais G, Nappi RE, Gabellari IC, Di Renzo GC, Genazzani AR, Bellafronte M, Roncolato M, Benedetto C (2010) Sumatriptan (50 mg tablets vs. 25 mg suppositories) in the acute treatment of menstrually related migraine and oral contraceptiveinduced menstrual migraine: a pilot study. Gynecol Endocrinol 26:773-779
6. Mannix LK, Martin VT, Cady RK, Diamond ML, Lener SE, White JD, Derosier FJ, McDonald SA (2009) Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol 114:106-113
7. Schreiber CP, Cady RK (2007) Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg. Clin Ther 29(Suppl):2511-2519 (Pubitemid 350299455)
8. Dowson AJ, Massiou H, Aurora SK (2005) Managing migraine headaches experienced by patients who self-report with menstrually related migraine: a prospective, placebo-controlled study with oral sumatriptan. J Headache Pain 6:81-87 (Pubitemid 40667559)
9. Landy S, Savani N, Shackelford S, Loftus J, Jones M (2004) Efficacy and tolerability of sumatriptan tablets administered during the mild-pain phase of menstrually associated migraine. Int J Clin Pract 58:913-919 (Pubitemid 39642611)
10. Nett R, Landy S, Shackelford S, Richardson MS, Ames M, Lener M (2003) Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine. Obstet Gynecol 102:835-842 (Pubitemid 37206421)
11. Salonen R, Saiers J (1999) Sumatriptan is effective in the treatment of menstrual migraine: a review of prospective studies and retrospective analyses. Cephalalgia 19:16-19 (Pubitemid 29136846)
12. Tuchman M, Hee A, Emeribe U, Silberstein S (2006) Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine. CNS Drugs 20:1019-1026 (Pubitemid 44912709)
13. Allais G, Acuto G, Cabarrocas X, Esbri R, Benedetto C, Bussone G (2006) Efficacy and tolerability of almotriptan versus zolmitriptan for the acute treatment of menstrual migraine. Neurol Sci 27(Suppl 2):S193-S197 (Pubitemid 44390141)
14. Loder E, Silberstein SD, Abu-Shakra S, Mueller L, Smith T (2004) Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallelgroup, double-blind, placebo-controlled study. Headache 44:120-130 (Pubitemid 38233753)
15. Massiou H, Jamin C, Hinzelin G, French Naramig Collaborative Study Group (2005) Efficacy of oral naratriptan in the treatment of menstrually related migraine. Eur J Neurol 12:774-781 (Pubitemid 41495134)
16. Bigal M, Sheftell F, Tepper S, Tepper D, Ho TW, Rapoport A (2008) A randomized double-blind study comparing rizatriptan, dexamethasone, and the combination of both in the acute treatment of menstrually related migraine. Headache 48:1286-1293
17. Nett R, Mannix LK, Mueller L, Rodgers A, Hustad CM, Skobieranda F, Ramsey KE (2008) Rizatriptan efficacy in ICHD-II pure menstrual migraine and menstrually related migraine. Headache 48:1194-1201
18. Martin V, Cady R, Mauskop A, Seidman LS, Rodgers A, Hustad CM, Ramsey KE, Skobieranda F (2008) Efficacy of rizatriptan for menstrual migraine in an early intervention model: a prospective subgroup analysis of the rizatriptan TAME (Treat A Migraine Early) studies. Headache 48:226-235 (Pubitemid 351178285)
19. Silberstein SD, Massiou H, McCarroll KA, Lines CR (2002) Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data. Headache 42:917-923 (Pubitemid 35285385)
20. Silberstein SD, Massiou H, Le Jeunne C, Johnson-Pratt L, McCarroll KA, Lines CR (2000) Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 96:237-242 (Pubitemid 30447346)
21. Diamond ML, Cady RK, Mao L, Biondi DM, Finlayson G, Greenberg SJ, Wright P (2008) Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines. Headache 48:248-258 (Pubitemid 351178257)
22. Allais G, Bussone G, D'Andrea G, Moschiano F, d'Onofrio F, Valguarnera F, Manzoni GC, Grazzi L, Allais R, Benedetto C, Acuto G (2011) Almotriptan 12.5 mg in menstrually related migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia 31:144-151
23. Bussone G, Allais G, Castagnoli Gabellari I, Benedetto C (2011) Almotriptan for menstrually related migraine. Expert Opin Pharmacother 12:1933-1943
24. Lionetto L, Fiorillo M, Martelletti P (2011) Efficacy and tolerability of almotriptan in menstrual migraine: a comment. Expert Opin Pharmacother 12:2279-2281
25. Newman LC, Harper S, Jones BA, Campbell J (2009) Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. J Womens Health (Larchmt) 18:1265-1273
26. MacGregor EA (2010) Prevention and treatment of menstrual migraine. Drugs 70:1799-1818
27. Pringsheim T, Davenport WJ, Dodick D (2008) Acute treatment and prevention of menstrually related migraine headache: evidence-based review. Neurology 70:1555-1563 (Pubitemid 351589510)
28. MacGregor EA, Pawsey SP, Campbell JC, Hu X (2010) Safety and tolerability of frovatriptan in the acute treatment of migraine and prevention of menstrual migraine: results of a new analysis of data from five previously published studies. Gend Med 7:88-108
29. Brandes JL, Poole A, Kallela M, Schreiber CP, MacGregor EA, Silberstein SD, Tobin J, Shaw R (2009) Short-term frovatriptan for the prevention of difficult-to-treat menstrual migraine attacks. Cephalalgia 29:1133-1148
30. Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC (2009) Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation. Headache 49:1283-1297
31. Silberstein SD, Elkind AH, Schreiber C, Keywood C (2004) A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Neurology 63:261-269 (Pubitemid 38971124)
32. Guidotti M, Mauri M, Barrila C, Guidotti F, Belloni C (2007) Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine. J Headache Pain 8:283-288 (Pubitemid 350214726)
33. Balbisi EA (2006) Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. Ther Clin Risk Manag 2:303-308 (Pubitemid 44349505)
34. Allais G, Bussone G, Airola G, Borgogno P, Gabellari IC, De Lorenzo C, Pavia E, Benedetto C (2008) Oral contraceptiveinduced menstrual migraine. Clinical aspects and response to frovatriptan. Neurol Sci 29(Suppl 1):S186-S190 (Pubitemid 351836998)
35. Allais G, Tullo V, Benedetto C, Zava D, Omboni S, Bussone G (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. Neurol Sci 32(Suppl 1):S99-S104
36. Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L (2011) Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. J Headache Pain 12:609-615
37. Bartolini M, Giamberardino MA, Lisotto C, Martelletti P, Moscato D, Panascia B, Savi L, Pini LA, Sances G, Santoro P, Zanchin G, Omboni S, Ferrari MD, Brighina F, Fierro B (2011) A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine. J Headache Pain 12:361-368
38. Headache Classification Subcommittee of the International Headache Society (2004) The international classification of headache disorders, 2nd edn. Cephalalgia 24(Suppl 1):9-160
39. Loder E (2010) Triptan therapy in migraine. N Engl J Med 363:63-70
40. Balbisi EA (2004) Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. Int J Clin Pract 58:695-705 (Pubitemid 39144585)
41. Antonaci F, De Cillis I, Cuzzoni MG, Allena M (2010) Almotriptan for the treatment of acute migraine: a review of early intervention trials. Expert Rev Neurother 10:351-364
42. Negro A, Lionetto L, Casolla B, Lala N, Simmaco M, Martelletti P (2011) Pharmacokinetic evaluation of frovatriptan. Expert Opin Drug Metab Toxicol 7:1449-1458